Clinical Trial Search

Primary: Percent Coefficient of Fat Absorption (CFA) — 88.55; 55.61 Percent CFA — p=<0.0001

Primary: Peel Force — 2.6; 2.1; 4.4; 3.4 Newton

Primary: ASES Score — 93.3; 89.0 units on a scale

Primary: Changs in Total Cholesterol — -0.42; -0.60; -0.46; -0.30 mmol/L

Primary: Percent Treatment Sessions Attended — 77.9; 85.9; 66.8; 66.6 Percentage of attended tx. sessions — p=<0.017

Primary: Persistence of Serum Bactericidal Antibody Titers in Children (at 40 Months of Age), Twenty-eight Months After Completing Primary Vaccination. — 1.26; 2.55; 1.08; 41…

Primary: Change From Baseline in Modified Psoriasis Area and Severity Index (mPASI) — -50.5; -64.3; -53.6 percentage of change

Primary: Clinical Global Impression (Change Version, Also Known as Improvement Version) — 3; 4 participants

Primary: Comparison of Antibody Responses of Investigational TIV to Control Vaccine in Terms of the Percentage of Subjects Achieving Seroconversion — 95; 94; 78; 87 Percentages

Primary: Change From Baseline to Week 24 in Body Mass Index (BMI) — 1.620; 1.800 kg/m^2

Primary: Pain Measured on Verbal Scale of 0-10 — 2.7; 1.7; 3; 2.1 units on a scale

Primary: Number of Participants With Acute Kidney Injury — 20; 14 participants

Primary: Change From Baseline in Personal and Social Performance (PSP) Scale Score at Week 52 — 50.65; 58.71; 5.35; 5.96 units on a scale — p=0.8595

Primary: 6 Minutes Walking Distance (6MWD) - Change From Baseline to Week 16 — 38.9; -5.5 Meters — p=<0.0001

Primary: Percentage of Participants With Pathological Complete Response (pCR) — 13 percentage of participants